These results indicate that Bcl-2 expression, tumor size, and cancer-associated lymphohistiocytic inflammation were the 3 significant and independent predictors of the outcome of female cats with ER+ and/or PR+ mammary carcinoma in this cohort. Here, BCL2 is linked to neoplasm.